The utility of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta-analysis

INTRODUCTION: The omission of the immunohistochemical proliferation marker Ki-67 labelling index (henceforth, simply Ki-67) from the 2015 WHO classification system of pulmonary neuroendocrine tumours (Lung-NETs) as a prognostic and grading criterion remains controversial. This systematic review alon...

Descripción completa

Detalles Bibliográficos
Autores principales: Naheed, Salma, Holden, Chloe, Tanno, Lulu, Jaynes, Eleanor, Cave, Judith, Ottensmeier, Christian H, Pelosi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720315/
https://www.ncbi.nlm.nih.gov/pubmed/31446421
http://dx.doi.org/10.1136/bmjopen-2019-031531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720315/
https://www.ncbi.nlm.nih.gov/pubmed/31446421
http://dx.doi.org/10.1136/bmjopen-2019-031531

Ejemplares similares